Search

Increased Surveillance Recommended for Children at Risk for Hematopoietic Malignancy Predisposition

OPACC
Nov 12, 2024
1 min read

Children with a genetic risk of developing myelodysplastic syndromes (MDS) and other hematopoietic malignancies (HM), such as leukemias and lymphomas, should receive intensive monitoring, in order to identify patients who would most benefit from hematopoietic stem cell transplantation (HSCT), according to a study in Clinical Cancer Research.

Comments

Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors

Cardiometabolic Considerations for Childhood Cancer Survivors Explained

Sex and Age May Influence Comorbidities in Pediatric ALL

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

Untreated GHD Linked to Adverse Outcomes in Childhood Cancer Survivors

Trial Shows Targeted Treatment for Childhood Brain Tumor is Safe

New approach speeds up personalized cancer treatment for young patients

Motor Deficits in Children Off Therapy for Acute Lymphoblastic Leukemia

Boys with cancer can face infertility as adults. Can storing their stem cells help?

HRD HSCT Shows Promise Among Pediatric Patients With Hematologic Cancers

Recent Posts